Yes, okay.
I'd like to move on to page 35, which is the pre-market evaluation and regulatory process improvement, which always sounds like good news for everybody, except for the phrase at the top that says “streamlining processes and collaborating more closely with other organizations”, etc. When we're talking about drug approvals, for example, “streamlining” is a word that rather scares me. I know that industry wants everything faster.
And I'm wondering what “other organizations” are. Is that the private companies, or is it other countries, or what?